These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 34550859)

  • 1. Nanovaccine: an emerging strategy.
    Das A; Ali N
    Expert Rev Vaccines; 2021 Oct; 20(10):1273-1290. PubMed ID: 34550859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.
    Korkmaz E; Balmert SC; Carey CD; Erdos G; Falo LD
    Expert Opin Drug Deliv; 2021 Feb; 18(2):151-167. PubMed ID: 32924651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria.
    Chen L; Kang Z; Shen J; Zhao R; Miao Y; Zhang L; Zheng Z; Zhang Z; Liu N; Wang C; Fang H; Zhou J; Wang Y; Liu Z; Yang Y; Chen Q
    Sci Bull (Beijing); 2024 Aug; 69(16):2565-2579. PubMed ID: 38918142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological basis for enhanced immunity of nanoparticle vaccines.
    Kelly HG; Kent SJ; Wheatley AK
    Expert Rev Vaccines; 2019 Mar; 18(3):269-280. PubMed ID: 30707635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen.
    Hashemi Goradel N; Nemati M; Bakhshandeh A; Arashkia A; Negahdari B
    Int Immunopharmacol; 2023 Apr; 117():109887. PubMed ID: 36841155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection.
    Xu F; Yuan Y; Wang Y; Yin Q
    Biomed Pharmacother; 2023 Feb; 158():114117. PubMed ID: 36528914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance.
    Xu Z; Zhou H; Li T; Yi Q; Thakur A; Zhang K; Ma X; Qin JJ; Yan Y
    Drug Resist Updat; 2024 Jul; 75():101098. PubMed ID: 38833804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges.
    Ahmad MZ; Ahmad J; Haque A; Alasmary MY; Abdel-Wahab BA; Akhter S
    Expert Rev Vaccines; 2020 Nov; 19(11):1053-1071. PubMed ID: 33315512
    [No Abstract]   [Full Text] [Related]  

  • 9. A Glance on Nanovaccine: A Potential Approach for Disease Prevention.
    Garg A; Agrawal R; Chopra H; Singh T; Chaudhary R; Tankara A
    Curr Pharm Biotechnol; 2024; 25(11):1406-1418. PubMed ID: 37861010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections.
    Chen H; Li Y; Li L; Yang Z; Wen Z; Liu L; Liu H; Chen Y
    Acta Biomater; 2023 Mar; 158():525-534. PubMed ID: 36572250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
    Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
    ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric nanostructure vaccines: applications and challenges.
    Simón-Vázquez R; Peleteiro M; González-Fernández Á
    Expert Opin Drug Deliv; 2020 Jul; 17(7):1007-1023. PubMed ID: 32476491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten density.
    Zhao Z; Powers K; Hu Y; Raleigh M; Pentel P; Zhang C
    Biomaterials; 2017 Apr; 123():107-117. PubMed ID: 28167389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-adjuvanting cancer nanovaccines.
    Liao Z; Huang J; Lo PC; Lovell JF; Jin H; Yang K
    J Nanobiotechnology; 2022 Jul; 20(1):345. PubMed ID: 35883176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanovaccines: A game changing approach in the fight against infectious diseases.
    Priyanka ; Abusalah MAH; Chopra H; Sharma A; Mustafa SA; Choudhary OP; Sharma M; Dhawan M; Khosla R; Loshali A; Sundriyal A; Saini J
    Biomed Pharmacother; 2023 Nov; 167():115597. PubMed ID: 37783148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal and pulmonary vaccine delivery using particulate carriers.
    Jia Y; Krishnan L; Omri A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle vaccines.
    Zhao L; Seth A; Wibowo N; Zhao CX; Mitter N; Yu C; Middelberg AP
    Vaccine; 2014 Jan; 32(3):327-37. PubMed ID: 24295808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvants in cutaneous vaccination: A comprehensive analysis.
    Oladejo M; Tijani AO; Puri A; Chablani L
    J Control Release; 2024 May; 369():475-492. PubMed ID: 38569943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines.
    Chatzikleanthous D; O'Hagan DT; Adamo R
    Mol Pharm; 2021 Aug; 18(8):2867-2888. PubMed ID: 34264684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery strategies to enhance oral vaccination against enteric infections.
    Davitt CJ; Lavelle EC
    Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.